Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme

Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
doi: https://doi.org/10.1101/2021.07.09.21260251

Article usage

Article usage: July 2021 to March 2023

AbstractFullPdf
Jul 202129081291319
Aug 202174052172
Sep 2021775108236
Oct 2021391148155
Nov 2021535128336
Dec 202156093527
Jan 202225053441
Feb 202213420115
Mar 20221651782
Apr 20221032935
May 202277734
Jun 2022961218
Jul 202267512
Aug 202252719
Sep 202271920
Oct 2022133510
Nov 202244213
Dec 202243718
Jan 202346516
Feb 2023461213
Mar 20232422
Back to top
Posted July 13, 2021.
Download PDF
Data/Code
Email
Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme
Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
medRxiv 2021.07.09.21260251; doi: https://doi.org/10.1101/2021.07.09.21260251
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area